Nitraflax Hypermia & Testosterone Enhancing Tabs

by GAT · tablet or pill · 180 tablets

  • On the market (NIH)
  • UPC 8 59613 64881 5
  • DSLD label 18566
  • Serving 3 to 6 tablets; amounts per 3 tablets
  • 60 servings

Nitraflax Hypermia & Testosterone Enhancing Tabs by GAT lists one ingredient: clinically-studied testosterone-enhancing complex, without an amount per serving of 3 tablets. Its current label entered the NIH Dietary Supplement Label Database on February 25, 2013.

What is in Nitraflax Hypermia & Testosterone Enhancing Tabs?

Each row as the label prints it, per serving of 3 tablets. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

Nitraflax Hypermia & Testosterone Enhancing Tabs: Supplement Facts rows against the market (DSLD label 18566, January 2026 release)
IngredientAmount% DVAmong products listing it
NitraFlex Proprieceutical Blend4,058 mg
Vasoactive Arginase-Regulating NO Precursor Complexas (E)-5-(4-hydroxystyryl)benzene-1,3-diol, (S)-2-amino-5-guanidinopentanoic Acid, 2-Amino-5-(carbamoylamino) Pentanoic Acidin the blend, no amount given
Acute Energy, Focus, Intensity & Endurance Complexas 2-(Dimethylamino)ethanol, 2-acetylamino-3-(4-hydroxyphenyl)-propanoic acid, 2-Amino-4-(ethylcarbamoyl) butyric acidin the blend, no amount given
Clinically-Studied Testosterone-Enhancing Complexas Calcium fructopyranose boratein the blend, no amount given
Proprietary Nitraflex Nutrient Partitioning Blendas (1S3R,4R,5R)-3-[[3-(3,4-Dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-1,4,5-trihydroxycylohexanecarboxylic acid, 1,2-Dithiolane-3-Pentanoic Acid, 2 alpha-hydroxy ursolic acidin the blend, no amount given

Source: NIH ODS Dietary Supplement Label Database, label 18566 (entered February 25, 2013), version 9.4.0. See the label on DSLD. Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

Every amount on this label with a position sits within the middle 80% of the products that list the same ingredient; 1 ingredient sits inside a blend, so their amounts cannot be compared.

The NIH database records 3 servings a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

Which products have the closest formulas?

3 products list the very same ingredients; the nearest amounts come first.

Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
TAKE 3X DAILY
RECOMMENDED DOSAGE Under 200 Lbs: Take 3-4 tablets three times daily on an empty stomach (every day). Take the first 3-4 tablets in the morning at wake-up, the second 3-4 tablets before lunch, and the last 3-4 tablets before dinner. Over 200 Lbs: Same as above but take 5-6 tablets, three times daily. STACKING (SUPER INTENSE) MIXING NITRAFLEX TABLETS WITH NITRAFLEX POWDER: Take (stack) 3-4 tablets of Nitraflex Tablets with one (1) level scoop of Nitraflex Powder 30 minutes before intense training for maximum effects. Stack Nitraflex tablets and powder with Prolein, Muscle Martini, Testrol, Fornatab, Jetfuse NOX, and JetMASS.
Warnings
Do not use if you are pregnant, nursing, prone to dehydration or exposed to excessive heat.
Reduce or discontinue use if sleeplessness, tremors, dizziness, nervousness, headaches, or heart palpitations occur.
KEEP OUT OF THE REACH OF CHILDREN AND PETS
WARNING: Before using Nitraflex, seek advice from a health care practitioner if you are unaware of your current health condition or have any pre-existing medical condition including but not limited to: high or low blood pressure, cardiac arrhythmia, stroke, heart, liver or thyroid disease, anxiety, depression, seizure disorder, psychiatric disease, diabetes, pernicious anemia, difficulty urinating due to prostate enlargement or if you are taking an MAO inhibitor or any other medication.
Not intended for use by persons under the age of 18.
Allergens and what it does not contain
STIMULANT-FREE CREATINE-FREE

Source: label statements in DSLD label 18566.

What else is on the label?

Other ingredients: Microcrystalline Cellulose, Dextrose, Sodium Starch Glycolate, Di-Calcium Phosphate, Magnesium Stearate, Stearic Acid, FD&C Blue # 1, FD&C Yellow # 5, Titanium Dioxide.

How many labels does Nitraflax Hypermia & Testosterone Enhancing Tabs have?

One label is on file, entered on February 25, 2013.

  1. Label 18566 (current) Entered February 25, 2013 · on the market · 180 tablets · UPC 8 59613 64881 5

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names GAT/German American Technologies (distributor), Stamford, CT. All GAT products.

Where next?